Ind-Swift Laboratories Financial Results
Ind-Swift Laboratories approved its FY26 audited financial results and re-appointed V. Kumar & Associates as cost auditors. Performance reflects full-year operations post-amalgamation with Ind Swift Limited.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
37 announcements with these filters
Ind-Swift Laboratories approved its FY26 audited financial results and re-appointed V. Kumar & Associates as cost auditors. Performance reflects full-year operations post-amalgamation with Ind Swift Limited.
Ind-Swift Laboratories scheduled a board meeting for May 28, 2026, to approve audited financial results. Investors should track the subsequent outcome for performance data.
Ind-Swift Laboratories Limited announced the successful passage of four special resolutions via postal ballot. Shareholders approved the redesignation of Sh. N.R. Munjal and the appointments of Sh. Himanshu Jain and Sh. Sahil Munjal as Managing Directors. Additionally, the payment of remuneration to Whole-Time Director Sh. Rishav Mehta was approved with a requisite majority.
HCP Investments, a non-promoter entity, sold 6,503,423 equity shares of Ind-Swift Laboratories Limited between April 13 and April 17, 2026. This disposal represents 7.5% of the company's total paid-up share capital. Following the transaction, HCP Investments retains a 1.149% stake in the company.
HCP Investments, a non-promoter entity, sold 6,503,423 equity shares of Ind-Swift Laboratories Limited via the open market between April 13 and April 17, 2026. This disposal represents 7.5% of the company's paid-up share capital, reducing HCP's holding to 1.149%.
Ind-Swift Laboratories clarified that the sudden volume spurt in its shares is market-driven. The company noted a recent disclosure on April 7, 2026, regarding a favorable arbitration award from a tribunal rejecting all claims by PI Industries Limited, resulting in NIL financial impact.
Ind-Swift Laboratories Limited clarified to the NSE regarding a sudden spurt in share volume. The company attributed the movement to market factors and a recent disclosure about an arbitration award involving PI Industries Limited, which concluded with nil financial impact.